Ovation Science Inc. OVATF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

21/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Ovation Science Inc. (OVATF) reported total assets of $63.9K and total liabilities of $1.15M for fiscal year 2024, resulting in total equity of $-1.09M.

The company held $3.31K in cash and short-term investments. Total debt stood at $268.48K, with net debt of $265.17K. The Debt-to-Equity (D/E) ratio was -0.25 (conservative).

Current ratio is 0.06, which may signal tight short-term liquidity. Interest coverage is -9.6x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (35/100) — Total assets $63.9K and equity $-1.09M support the company's competitive scale

Overall SharesGrow Score: 19/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

35/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Ovation Science Inc. Balance Sheet History

Metric	FY2024	FY2023	FY2022	FY2021
Total Assets	$63.9K	$76.89K	$104.89K	$769.9K
Total Liabilities	$1.15M	$728.99K	$187.84K	$63.74K
Total Debt	$268.48K	$192.62K	$41.14K	$0.00
Cash & Investments	$3.31K	$48.85K	$28.9K	$647.56K
Total Stockholders Equity	$-1.09M	$-652.1K	$-82.95K	$706.16K